Drugplain

RIFAMPIN 150 mg/1

rifampin · CAPSULE · PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS

10 Recalls on Record
Plain English

RIFAMPIN is a capsule containing rifampin at 150 mg/1, taken oral. Manufactured by PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS.

Key Facts

Brand Name
RIFAMPIN
Generic Name
rifampin
NDC Code (Product)
24658-801
Manufacturer
PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
Strength
150 mg/1
Dosage Form
CAPSULE
Route
ORAL
Marketing Status
Application #
ANDA064150
Drug Class
Rifamycin Antibacterial [EPC]
Marketing Start
03/14/2023

Recall History

10 Recalls on Record
Class III08/05/2014

Akorn, Inc.

Failed Impurity/Degradation Specification; high out of specification result for 23 transacetyl impurity at the 22 month stability time point

TerminatedVoluntary: Firm initiated
Class II07/28/2022

Lupin Pharmaceuticals Inc.

CGMP Deviations:OOS result was observed in 1-Methyl-4-Nitroso Piperazine (MNP) impurity.

TerminatedVoluntary: Firm initiated
Class II06/04/2015

Fresenius Kabi USA, LLC

Failed Impurities/Degradation Specifications; out-of-specification for color, impurity, and degradation

TerminatedVoluntary: Firm initiated
Class II12/20/2022

RemedyRepack Inc.

Failed Impurities/Degradation specifications

TerminatedVoluntary: Firm initiated
Class II04/26/2023

Akorn, Inc.

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

OngoingVoluntary: Firm initiated
Class II09/21/2022

Akorn, Inc.

Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).

OngoingVoluntary: Firm initiated
Class II02/26/2013

Sanofi-Synthelabo

Subpotent Drug: During review of retain samples, the manufacturer observed low fill in some capsules, which was related to an issue detected with the encapsulating equipment.

TerminatedVoluntary: Firm initiated
Class II01/05/2024

Lupin Pharmaceuticals Inc.

Subpotent Drug and Failed Impurities/Degradation Specifications

TerminatedVoluntary: Firm initiated
Class II01/11/2024

Amerisource Health Services LLC

Failed Impurities/Degradation Specification.

TerminatedVoluntary: Firm initiated
Class II03/07/2013

Sanofi US

Subpotent drug: low fill volume in some of the capsules

TerminatedVoluntary: Firm initiated

Frequently Asked Questions

What is RIFAMPIN used for?

RIFAMPIN contains rifampin. It is a capsule taken oral. Consult your doctor for specific uses.

Is RIFAMPIN a controlled substance?

RIFAMPIN is not classified as a controlled substance by the DEA.

What is the generic name for RIFAMPIN?

The generic name for RIFAMPIN is rifampin. There are 8 other brand versions of rifampin.

What is the NDC code for RIFAMPIN 150 mg/1?

The NDC (National Drug Code) for RIFAMPIN 150 mg/1 is 24658-801, listed by PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS.

Product NDC

24658-801

Package NDC

24658-801-30

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)